CereScan’s Latest Patent for its Neuroimaging Database Now Covers All Brain Activity Measurement Methods

CereMetrix CereScan Patent

In response to an application filed with the United States Patent and Trademark Office, CereScan® has broadened the parameters on its automated diagnostic assistance and intelligent support system, CereMetrix®, which uses quantitative measurements to assist in the diagnosis and study of complex brain disorders.  Through award of a second patent, the company may now claim exclusive use of its neuroimaging database systems and methods in the measurement of all types of brain activity.  The patent expands CereScan’s intellectual property and use of its wholly owned data warehouse, known to be the most comprehensive store of functional brain imaging data, associated patient demographic, clinical information and biomarkers worldwide.

“CereScan® is transforming the future of advanced brain diagnostics and use of intelligent learning to benefit those suffering from and studying complex brain disorders,” said John Kelley, CEO and Chairman of CereScan®. “The expansion of our patent allows us to apply key learnings to all manners of brain measurement, and vastly expands the potential for advancements in brain science using technology.”

Read More: CereScan Taps The Ohio State University to Advance Functional Brain Diagnostic System

Headquartered in Denver, CereScan® uses its patented methods, combining patient-clinical information, functional brain imaging and advanced processing software to help medical professionals identify abnormal brain physiology and activity using correlative data and pattern matching contained within its extensive data warehouse.  Through the application of technology to traditional medical practice, CereScan® has assumed a leadership role in advancing precision brain diagnostics and science.  Its first patent was awarded in September of 2014, and allowed for exclusive utilization of it systems and methods under more limited claims.

CereScan® is uniquely positioned to capitalize on a planned release of CereMetrix®, its MAaS (Medical Analytics as a Service) platform in 2017.  Its patented technology is considered by industry insiders to be a positive disruptor in the field of diagnostic radiology.  CereScan’s MAaS product suite incorporated into its CereMetrix® offering is being labeled as revolutionary, based on early feedback from Radiologists, Neurologists, and Psychiatrists who have had a chance to experiment with early release versions.

About CereScan® 
CereScan® combines state-of-the-art brain imaging technologies with a patient centered model of care to provide the highest level of neurodiagnostics anywhere. Using quantitative functional brain imaging, advanced imaging software, and an extensive library of clinical data, the CereScan medical team provides physicians with unmatched objective diagnostic information. CereScan helps patients and their physicians better understand the neurological basis of their conditions. In a variety of legal settings, CereScan provides unbiased evidence to attorneys and their clients regarding traumatic and toxic brain injuries. For researchers, CereScan provides independent pre- and post-treatment measures of organic changes in the brain along with measures of symptoms related to the brain disorder of interest. For more information, please call (866) 722-4806 or visit http://www.CereScan.com. Connect with CereScan on Twitter @CereScan and on Facebook at Facebook.com/CereScan.

About CereMetrix®

CereMetrix® is an advanced healthcare analytics ecosystem that provides radiologists, practitioners and researchers with precise data about their patient’s brain health. Each new patient’s data will be compared to a library of patients with similar brain patterns, medical histories, and clinical symptoms. The unique brain diagnostic system and ever-expanding data warehouse includes over 7,000 scan encounters, including patients’ medical histories, family histories, symptoms, prior treatments, incoming diagnoses, outgoing diagnoses, and brain scans, among other data points. Each scan is composed of over 262,000 data points that measure activity levels in up to 160 brain regions derived from comparisons to normative data.

CereScan® Extends Brain Diagnostics Services to Southern California

CereScan Southern California

CereScan, a company dedicated to providing advanced brain diagnostics to practitioners and patients, today announced its availability to residents in Southern California. Since 2009, CereScan has used its patented brain evaluation process to help medical providers and their patients find a more complete and accurate diagnosis.

CereScan’s functional brain imaging and analytical services will be offered at Imaging Healthcare Specialists (IHS) through their Encinitas facility near San Diego, California. CereScan is now partnered with nine affiliated clinics across eight states, including its most recent partner at Northwest Community Healthcare in metro Chicago. The addition of IHS expands CereScan’s national functional brain imaging network to provide services to those individuals suffering from a variety of complex, brain-based disorders – ranging from chronic traumatic brain injuries to Alzheimer’s and other dementias to toxic exposure.

“We selected IHS as our next launch partner because of their stellar reputation in the San Diego marketplace, and their use of the highest quality imaging technology. We’ve received multiple requests from across the state from medical professionals and patients seeking our statistically measured brain diagnostics process, and we are thrilled to now be able to offer those services.” said John Kelley, CEO and Chairman of CereScan. “With over 30 years of imaging services experience, IHS’s patient-focused, outpatient center is an ideal relationship.  We are honored to be partnered with them.”

Read More: CereScan Participates in Largest Brain Amyloid Scan Research Study

Headquartered in Denver, CereScan uses its patented process to combine patient clinical information, functional brain imaging and advanced processing software to help provide clarity around complex brain disorders that often have overlapping symptoms. As an example, patients with a traumatic brain injury often experience personality changes, poor concentration and fatigue, which can also be common symptoms for bipolar disorder and dementia.

Through this partnership, IHS has integrated CereScan’s patented process, using qSPECT (quantitative Single Photon Emission Computed Tomography) imaging, to assist referring physicians by clarifying non-specific symptoms to enhance the physician’s ability to accurately diagnose and have better outcomes.

Medical providers and patients interested in pursuing CereScan’s brain diagnostic process can call toll free (866) 722-4806 or email pcc@cerescan.com .

About CereScan® 
CereScan combines state-of-the-art qSPECT, qEEG and PET/CT brain imaging technologies with a patient centered model of care to provide the highest level of neurodiagnostics anywhere. Using quantitative functional brain imaging, advanced imaging software, and an extensive library of clinical data, the CereScan medical team provides physicians with unmatched objective diagnostic information. CereScan helps patients and their physicians better understand the neurological basis of their conditions. In a variety of legal settings, CereScan provides unbiased evidence to attorneys and their clients regarding traumatic and toxic brain injuries. For researchers, CereScan provides independent pre- and post-treatment measures of organic changes in the brain along with measures of symptoms related to the brain disorder of interest. For more information, please call (866) 722-4806 or visit http://www.CereScan.com. Connect with CereScan on Twitter @CereScan and on Facebook at Facebook.com/CereScan.

About Imaging Healthcare Specialists

Imaging Healthcare Specialists (IHS) is a leading outpatient provider of San Diego medical imaging services, diagnostic imaging, and radiology. Offering over 30 years of imaging services experience, IHS has earned an outstanding reputation for providing the highest quality medical imaging technology, highly specialized expertise and exceptional customer service to physicians and patients. Imaging Healthcare Specialists services southern California, including Riverside County and San Diego County.

NCH in Metro Chicago Joins CereScan Family to Help Patients with Head and Chronic Brain Injuries

CereScan Functional Brain Imaging and NCH

CereScan® has increased its functional brain imaging diagnostics network with the addition of Northwest Community Healthcare (NCH) in Arlington Heights. Patients in the Midwest region who are suffering from lingering head and brain injuries may now use the nation’s leading provider of statistically measured brain diagnostics to understand the biological basis of their symptoms for a more direct path to treatment and recovery.

“We’re honored to partner with a nationally recognized provider with some of the top Radiologists in the Great Lakes region at Northwest Community Healthcare,” said John Kelley, CEO and chairman of CereScan. “Our alliance will allow CereScan’s functional brain diagnostic services to be available to patients and practitioners in the Midwest region.  We pursued a relationship with NCH because our values and philosophy about healthcare are closely aligned.”

CereScan Functional Brain ImagingHeadquartered in Denver, CereScan uses its patented process to combine patient-clinical information, functional brain imaging and advanced processing software to help medical providers and their patients find a more complete and accurate diagnosis. Through its agreement, NCH has integrated CereScan’s patented process, using qSPECT (quantitative Single Photon Emission Computed Tomography) imaging data to assist referring physicians in the evaluation of complex neurological conditions.

“CereScan values the practice philosophy of NCH. Both parties believe that every person is unique and so is their diagnosis and treatment,” said neurosurgeon Shaun T. O’Leary, M.D., Ph.D., FAANS. “Through the clinical data, the innovations and the imaging software available through CereScan, we have a plethora of resources to make NCH an even higher-quality institution for brain disorders.”

Dr. O’Leary joined NCH’s Medical Group in December 2014 and is helping lead the hospital’s growth of neurosurgical patient care. NCH is the only hospital in Illinois to receive the 2017 Healthgrades® Neurosciences, Stroke Care and Cranial Neurosurgery Excellence Award. NCH was named one of America’s 100 Best Hospitals for Stroke Care for its performance in 34 of the most common inpatient procedures and conditions, as defined by Healthgrades, which evaluated nearly 4,500 hospitals across the country.

Headed by Dr. O’Leary, NCH’s Neuroscience Center will provide patients with full-service care for brain injuries. The NCH Neuroscience Center specializes in treating complex neurological conditions affecting the brain, nerves and spinal cord.

To make an appointment with Dr. O’Leary, please fill out our Contact Us form or call (866) 722-4806.

About Northwest Community Healthcare (NCH)
Serving Chicago’s northwest suburbs since 1959, NCH is a comprehensive, patient-centered system of care that serves more than 350,000 outpatients each year and more than 20,000 inpatients treated annually at the 489-bed acute care hospital in Arlington Heights. The award-winning hospital holds the prestigious Magnet designation for nursing excellence, is designated as a Primary Stroke Center, and earned the Joint Commission’s Gold Seal of Approval in 2015.  NCH has four Immediate Care locations in the northwest suburbs. NCH has a medical staff of more than 1,000 physicians, which includes the board-certified primary care doctors and specialists of the NCH Medical Group. These physicians have selected our facility as a place where they want to treat and care for their private patients. For more information, or to find a doctor on the NCH Medical staff, visit www.nch.org.

 

CereScan Joins World-Renowned Psychiatrist Dr. Bruce Perry at Childhood Trauma Conference

CereScan, the nation’s leader in providing statistically measured brain diagnostics, was invited by Dr. Bruce Perry, MD, PhD, to participate with him in presenting advances in implementation and innovation in practice, program development, and policy related to childhood trauma during the 2nd International Neurosequential Model Symposium. The event, held at the Banff Centre in Banff, Alberta, Canada on June 8-10, 2016, will feature innovations in research, clinical practice and education in all areas related to maltreatment and trauma in children.
Read more